Physician

Nguyen Pham Tran, M.D.

According to 2025 Medicare claims, Nguyen Tran, M.D. (NPI: 1558578476) practices allergy/immunology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is ALLERGY AND ASTHMA CARE, P.A. (NPI: 1821194390; TIN: 48-0971495) and primary practice location at 66211-1371.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 10,364 HCPCS/CPT codes, and received $561,986 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,190 prescription claims across 323 beneficiaries totaling $234,841 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 154 claims. Open Payments data shows 156 records totaling $3,121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $56,249 to $561,986. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,425 and ending at $3,495.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	179	3,474	$56,249
2016	173	4,585	$94,321
2017	176	7,683	$169,972
2018	201	7,992	$188,583
2019	192	8,507	$223,310
2020	167	7,200	$215,309
2021	181	8,416	$273,043
2022	271	8,425	$287,763
2023	300	8,999	$384,270
2024	270	10,364	$561,986

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	546	$54,233
2016	140	700	$88,371
2017	166	870	$155,370
2018	208	849	$147,891
2019	192	784	$163,856
2020	221	845	$168,101
2021	224	750	$159,226
2022	227	685	$129,488
2023	220	631	$110,750
2024	323	1,190	$234,841

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	135	$226,980
2016	N/R	143	$232,682
2017	N/R	167	$168,622
2018	N/R	172	$115,295
2019	N/R	185	$140,236
2020	N/R	140	$124,987
2021	N/R	99	$136,382
2022	N/R	190	$219,057
2023	N/R	178	$194,513
2024	N/R	154	$196,957

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	164	366	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	30	34	$59
95165	Professional service for preparation and provision of 1 or more antigens	102	1,138	$10
95117	Professional service for multiple injections of allergen	87	514	$8
89190	Nasal smear for eosinophils (allergy related white blood cells)	46	62	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	2,700	$56,186
Cuvitru	Immun Glob G(Igg)/Gly/Iga Ov50	11	308	$23,435
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	30	1,020	$21,282
Breo Ellipta	Fluticasone/Vilanterol	30	1,020	$13,495
Fluticasone Propionate Hfa	Fluticasone Propionate	19	660	$4,994

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	39	$141,401
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	13	$52,215
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	51	$2,940
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	51	$401

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	156	$3,121	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nguyen Pham Tran, M.D.?

Tedicare shows public-source Medicare data for Nguyen Pham Tran, M.D. (NPI 1558578476), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nguyen Pham Tran, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nguyen Pham Tran, M.D.?

Nguyen Pham Tran, M.D. is linked to ALLERGY AND ASTHMA CARE, P.A. (billing NPI 1821194390) in the available physician profile data.

Does Nguyen Pham Tran, M.D. have Open Payments data?

Nguyen Pham Tran, M.D. has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.